Cardiac allograft tolerance induction with limited immunosuppression

Journal of Surgical Research

Volumn 61, Issue 2, 1996, Pages 355-360

  Cohen, Dennis S ^a   Fisher, Robert A ^a   Tarry, Wallace C ^a   Tawes, John W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYCLOSPORIN G; IMMUNOSUPPRESSIVE AGENT; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TRANSFUSION; BODY WEIGHT; CONTROLLED STUDY; DRUG TOXICITY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029942510     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0129     Document Type: Article

References (25)

1. Annual Report of the U.S. Scientific Registry for Organ Transplantation and the Organ Procurement and Transplantation Network Richmond, VA: UNOS, 1993.
2. Vezina, C., Kudelski, A., and Sehgal, S. N. Rapamycin (AY22989) 1. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiotics 28: 721, 1975.
3. Sehgal, S. N., and Bansbach, C. C. Rapamycin: In Vitro profile of a new immunosuppressive macrolide. Ann. NY Acad. Sci. 685: 58, 1993.
4. Kimball, P. M., Kerman, R. H., and Kahan, B. D. Rapamycin and cyclosporine produce synergistic but nonidentical mechanisms of immunosuppression. Transplant Proc. 23: 1027, 1991.
5. Yakimets, W. J., Lakey, J. R. T., and Yatscoff, R. W., et al. Prolongation of canine pancreatic islet allograft survival with combined rapamycin and cyclosporine therapy at low doses: Rapamycin efficacy is blood level related. Transplantation 56: 1293, 1993.
6. Fryer, J., Yatscoff, R. W., and Pascoe, E. A., et al. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model. Transplantation 55: 340, 1993.
7. Jeffery, J. R. Cyclosporine analogues. Clin. Biochem. 24: 15, 1991.
8. Salvatierra, O., Vincenti, F., Amend, W., et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation: a new approach. Ann. Surg. 192: 543, 1980.
9. Marquet, R. L., and Heystek, G. A. Induction of suppressor cells by donor-specific blood transfusions and heart transplantation in rats. Transplantation 31: 272, 1981.
10. Terasaki, P. I. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. Transplantation 37: 119, 1984.
11. MacLeod, A. M., Mason, R. J., Stewart, K. N., et al. Association of Fc receptor-blocking antibodies and human renal transplant survival. Transplantation 34: 273, 1982.
12. Downey, W. E., Baldwin, W. M., and Sanfilippo, F. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of anti-idiotypic antibodies and reduced alloantibody responses. Transplantation 49: 160, 1990.
13. Fisher, R. A., Cohen, D. S., Alexander, J. W., et al. A comparison of a 5 mg/kg and 10 mg/kg cyclosporine A loading dose with single and multiple donor specific transfusions on rat cardiac allograft survival. Transplant Proc. 26: 3056, 1994.
14. Cofer, B. R., Davies, C. B., Alexander, J. W., et al. Effects of pre- and post engraftment donor-specific transfusions and cyclosporine on the enhancement of experimental allograft survival. J. Surg. Res. 52: 663, 1992.
15. Ono, K., and Lindsey, E. Improved technique of heart transplantation. J. Thorac. Cardiovasc. Surg. 57: 225, 1969.
16. Davies, C. B., Madden, R. L., Alexander, J. W., et al. Effect of a short course of rapamycin, cyclosporin A and donor-specific transfusion on rat cardiac allograft survival. Transplantation 55: 1107, 1993.
17. 2-cyclosporine (cyclosporine G) in a rat renal allograft model. Transplantation 44: 9, 1987.
18. 2)-cyclosporineless potent than cyclosporine A in rats with lung and heart transplants. Transplantation 44: 5, 1987.
19. Kupiec-Weglinski, J. W., Filho, M. A., Strom, T. B., et al. Sparing of suppressor cells: A critical action of cyclosporine. Transplantation 38: 97, 1984.
20. Kahan, B. D., Chang, J. Y., and Sehgal, S. N. Preclinical evaluation of a new potent immunosuppressive agent, rapamycin. Transplantation 52: 185, 1991.
21. Kimball, P. M., Kerman, R. H., and Kahan, B. D. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine. Transplantation 51: 486, 1991.
22. Fisher, R. A., Cohen, D. S., Ben-Ezra, J. M., et al. Induction of long term graft tolerance and donor/recipient chimerism. J. Surg. Res. in press, 1995.
23. Cohen, D. S., Fisher, R. A., Ben-Ezra, J. M., et al. Tolerance induction with rapamycin does not require chimerism. Proc. Int. Sympo. Tolerance Induction, in press, 1995.
24. Brunson, M. E., Tchervenkov, J. I., and Alexander, J. W. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant, importance of timing and specificity when DST is given with cyclosporine. Transplantation 52: 545, 1991.
25. Ustinov, J. A., Lahtinen, T. T., Bruggeman, C. A., et al. Direct induction of class II molecules by cytomegalovirus in rat heart microvascular endothelial cells is inhibited by ganciclovir (DHPG). Transplantation 58: 1027, 1994.